Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CORT | CORCEPT THERAPEUTICS INC | $90.52 | $23.73 | 281.52% | 196.78x | 151.70x | 12.29x | 15.23x | 1.40x | $119.79M | 1.27% | $637.99M | 6.11 | $9.62B | -1,400.87 | ||
| LQDA | LIQUIDIA CORP | $79.94 | $17.32 | 361.43% | 333.08x | 24.06x | 24.42x | 65.47x | 1.64x | $41.15M | 0.59% | $108.58M | 1.23 | $7.07B | 131.93 | ||
| XERS | XERIS BIOPHARMA HOLDINGS INC | $8.80 | $2.77 | 217.41% | 125.71x | 78.43x | 4.77x | 116.77x | 1.21x | $47.52M | 3.17% | $13.01M | 0.08 | $1.67B | 31.18 | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $267.47 | $93.33 | 186.59% | 61.35x | 35.60x | 8.29x | 33.21x | 1.25x | $641.34M | 1.80% | $1.08B | 8.09 | $36.97B | 39.99 | ||
| HALO | HALOZYME THERAPEUTICS INC | $77.81 | $70.06 | 11.06% | 26.29x | 9.37x | 6.09x | 42.02x | 0.47x | $667.65M | 7.26% | $219.64M | 1.86 | $11.06B | 17.73 | ||
| KRYS | KRYSTAL BIOTECH INC | $354.86 | $93.35 | 280.16% | 45.79x | 45.74x | 24.91x | 8.19x | 2.20x | $237.38M | 2.28% | $1.28B | 43.59 | $9.97B | 46.59 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $63.95 | $17.02 | 275.80% | 65.26x | 50.09x | 6.49x | 8.12x | 1.77x | $164.23M | 3.36% | $605.69M | 7.92 | $4.74B | 42.51 | ||
| ADMA | ADMA BIOLOGICS INC | $8.71 | $9.04 | -3.65% | 12.62x | 10.38x | 4.03x | 5.17x | 0.53x | $107.90M | 5.25% | $390.33M | 1.65 | $2.08B | 9.38 | ||
| RPRX | ROYALTY PHARMA PLC | $58.18 | $39.90 | 45.81% | 30.46x | 10.84x | 10.41x | 3.37x | 0.64x | $2.34B | 9.21% | $9.94B | 22.75 | $41.87B | 35.99 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $59.59 | $38.48 | 54.87% | 42.56x | 16.13x | 3.54x | 1.85x | 0.63x | $767.06M | 6.69% | $6.21B | 32.27 | $9.88B | 20.47 | ||
| VCEL | VERICEL CORP | $46.64 | $8.98 | 419.61% | 108.47x | 96.74x | 8.11x | 6.69x | 2.28x | $47.49M | 2.00% | $356.23M | 7.02 | $2.37B | 58.56 | ||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $247.53 | $48.37 | 411.78% | 526.66x | 9.56x | 3.45x | 3.43x | 1.78x | $1.30B | 8.47% | $4.53B | 73.22 | $19.09B | 28.28 | ||
| ASND | ASCENDIS PHARMA A | $261.00 | $78.94 | 230.64% | 27.66x | 17.94x | 15.92x | 28.24x | 2.86x | $52.94M | 0.33% | $574.09M | 9.24 | $16.59B | 177.92 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $303.39 | $96.64 | 213.93% | 38.40x | 33.13x | 21.98x | 6.10x | 1.80x | $122.22M | 2.03% | $997.32M | 50.16 | $6.42B | 28.45 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $33.77 | $35.05 | -3.65% | 13.35x | 8.98x | 2.17x | 2.15x | 0.51x | $341.79M | 17.50% | $910.35M | 15.75 | $1.52B | 6.43 | ||
| SPRO | SPERO THERAPEUTICS INC | $1.58 | $8.82 | -82.09% | 5.85x | -5.34x | 1.48x | 1.73x | 0.07x | $7.24M | 7.97% | $52.93M | 0.92 | $37.83M | 2.44 | ||
| TGTX | TG THERAPEUTICS INC | $54.87 | $21.40 | 156.35% | 17.04x | 38.88x | 11.32x | 14.40x | 3.82x | -$14.19M | -0.18% | $583.13M | 4.04 | $8.71B | 58.05 | ||
| TECH | BIO-TECHNE CORP | $72.12 | $16.46 | 338.27% | 101.58x | 34.57x | 9.31x | 5.41x | 1.86x | $269.60M | 2.39% | $2.09B | 13.34 | $11.37B | 44.43 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $485.65 | $163.88 | 196.34% | 28.55x | 25.11x | 10.10x | 6.37x | 2.11x | $3.71B | 3.01% | $19.36B | 76.20 | $119.75B | 22.20 | ||
| EXEL | EXELIXIS INC | $55.92 | $30.55 | 83.06% | 17.92x | 17.16x | 6.08x | 7.26x | 1.28x | $917.69M | 6.35% | $1.94B | 7.49 | $14.00B | 13.26 | ||
| UTHR | UNITED THERAPEUTICS CORP | $535.67 | $235.81 | 127.16% | 18.29x | 19.62x | 7.35x | 3.85x | 2.10x | $1.02B | 4.36% | $5.90B | 135.66 | $21.46B | 12.52 | ||
| NAGE | NIAGEN BIOSCIENCE INC | $3.28 | $2.09 | 57.12% | 13.67x | 14.08x | 2.01x | 3.17x | 1.28x | $4.11M | 1.55% | $82.33M | 1.03 | $197.26M | 9.29 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $676.69 | $426.78 | 58.56% | 15.90x | 14.48x | 4.72x | 2.26x | 1.08x | $4.11B | 5.84% | $31.42B | 302.15 | $70.69B | 12.30 | ||
| VCYT | VERACYTE INC | $59.13 | $8.86 | 567.55% | 53.27x | 53.32x | 8.68x | 3.51x | 6.27x | $155.34M | 3.30% | $1.34B | 16.90 | $4.49B | 39.05 | ||
| INCY | INCYTE CORP | $117.25 | $64.78 | 80.99% | 16.08x | 14.71x | 4.36x | 4.17x | 1.43x | $1.45B | 6.21% | $5.62B | 28.21 | $20.00B | 10.69 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.